Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial

By sjmartinez • August 1, 2024

Cooper SE, Zhang S, Haines D, Mayer KH, Amico KR, Landovitz RJ, Hendrix CW, Marzinke MA, Chege W, McCauley M, Gulick RM. Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial. AIDS Behav. 2024 Jul 31. doi: 10.1007/s10461-024-04451-7. Epub ahead of print. PMID: 39083151.

Tags: Adherence, CASI, HIV prevention, Infectious Diseases, Maraviroc, PrEP, Publications, Tenofovir

Rare mycetoma caused by Raghukumaria species, a mangrove-derived dematiaceous fungus in a kidney transplant patient

Gonzalez-Ferrer S, Yanagimoto-Ogawa L, Zhuo R, Matysiak Match CJ, Dayo A, Kang Y, Yang S. Rare mycetoma caused by Raghukumaria species, a mangrove-derived dematiaceous fungus in a[...]

Cannabis use, risk of cannabis use disorder, and anxiety and depression among bisexual patients: A comparative study of sex and sexual identity differences in a large health system

Setrakian N, Gelberg L, Koerber J, Chung UY, Akabike WN, Gorbach PM, Seamans MJ, Shoptaw S, Cerezo A, Javanbakht M. Cannabis use, risk of cannabis[...]

Host targets of candidalysin

Lin J, Filler SG. Host targets of candidalysin. PLoS Pathog. 2025 Jun 23;21(6):e1013284. doi: 10.1371/journal.ppat.1013284. PMID: 40549807; PMCID: PMC12184922.